Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).

A. Roddick (London, United Kingdom)

Source: International Congress 2017 – PAH and CTEPH
Session: PAH and CTEPH
Session type: Thematic Poster
Number: 2406
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Roddick (London, United Kingdom). Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).. 2406

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017

Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018


Epoprostenol dosing by concomitant therapies in the PROSPECT registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021



Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Venous thromboembolic disease (VTD) associated with inflammatory bowel disease (IBD): RIETE´s experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Chronic Thromboembolic Pulmonary Hypertension related to ICD
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018


Characteristics of patients with pulmonary hypertension in end stage renal disease
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Prognosis factors of recurrent pulmonary thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Sleep Disordered Breathing (SDB) and Chronic Thromboembolic Pulmonary Hypertension: the Effects of Pulmonary Endoarterectomy
Source: International Congress 2017 – CPAP therapy
Year: 2017


Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


LATE-BREAKING ABSTRACT: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH): 2-year results from the CHEST-2 long-term extension
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014


Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Improving the safety of right heart catheterisation in sickle cell disease
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014